| scholarly article | Q13442814 |
| P2093 | author name string | Brendan Lee | |
| Kilian Guse | |||
| Masataka Suzuki | |||
| John R Rodgers | |||
| Racel Cela | |||
| Gautam Sule | |||
| P2860 | cites work | Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death | Q24563654 |
| Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 | ||
| Tolerogenic dendritic cells: all present and correct? | Q33811958 | ||
| Tolerogenic dendritic cells: cytokine modulation comes of age. | Q34523591 | ||
| T cell memory | Q34542272 | ||
| 9-cis-Retinoic acid (9cRA), a retinoid X receptor (RXR) ligand, exerts immunosuppressive effects on dendritic cells by RXR-dependent activation: inhibition of peroxisome proliferator-activated receptor gamma blocks some of the 9cRA activities, and p | Q34579180 | ||
| Effect of B-cell depletion using anti-CD20 therapy on inhibitory antibody formation to human FVIII in hemophilia A mice | Q34707338 | ||
| Dendritic cell control of tolerogenic responses | Q34982085 | ||
| NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo. | Q35226121 | ||
| Suppression of the immune response to FVIII in hemophilia A mice by transgene modified tolerogenic dendritic cells | Q35285735 | ||
| The regulatory T cell family: distinct subsets and their interrelations | Q35603236 | ||
| Regulatory T cells: friend or foe in immunity to infection? | Q35934156 | ||
| The roles for cytokines in the generation and maintenance of regulatory T cells | Q36563513 | ||
| Tolerogenic dendritic cells: the ins and outs of outcome. | Q36593189 | ||
| Tolerogenic dendritic cells and the quest for transplant tolerance | Q36879029 | ||
| Suppressive dendritic cells as a tool for controlling allograft rejection in organ transplantation: promises and difficulties | Q37132092 | ||
| Combined Administration of a Mutant TGF-β1/Fc and Rapamycin Promotes Induction of Regulatory T Cells and Islet Allograft Tolerance | Q37155930 | ||
| Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A. | Q37158890 | ||
| Immune tolerance with rituximab in congenital haemophilia with inhibitors: a systematic literature review based on individual patients' analysis | Q37232091 | ||
| STAT6 activation confers upon T helper cells resistance to suppression by regulatory T cells. | Q37369331 | ||
| A cellular viewpoint of anti-FVIII immune response in hemophilia A. | Q37376144 | ||
| Factor VIII-pulsed dendritic cells reduce anti-factor VIII antibody formation in the hemophilia A mouse model | Q37423529 | ||
| The molecular mechanisms of immunomodulation and tolerance induction to factor VIII. | Q37543609 | ||
| Memory CD4+ T cells do not induce graft-versus-host disease | Q39778135 | ||
| Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors | Q40942254 | ||
| Induction of tolerance to factor VIII by transient co-administration with rapamycin. | Q41824863 | ||
| Prophylactic immune tolerance induced by changing the ratio of antigen-specific effector to regulatory T cells | Q42362478 | ||
| B-cell-delivered gene therapy induces functional T regulatory cells and leads to a loss of antigen-specific effector cells | Q42502298 | ||
| Nonredundant roles of IL-10 and TGF-β in suppression of immune responses to hepatic AAV-factor IX gene transfer | Q42786561 | ||
| Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells. | Q43190647 | ||
| Dendritic cell function after gene transfer with adenovirus-calcium phosphate co-precipitates | Q43555422 | ||
| Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo | Q43687301 | ||
| Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells | Q44986020 | ||
| Antigen-specific modulation of murine IgE and IgG2a responses with glutaraldehyde-polymerized allergen is independent of MHC haplotype and Igh allotype | Q45247106 | ||
| Prevention and treatment of factor VIII inhibitors in murine hemophilia A. | Q45865107 | ||
| Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. | Q45868863 | ||
| Induction of antigen-specific CD4+ T-cell anergy and deletion by in vivo viral gene transfer | Q45874902 | ||
| Reduction of the immune response to factor VIII mediated through tolerogenic factor VIII presentation by immature dendritic cells | Q45880542 | ||
| Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. | Q45998381 | ||
| Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques. | Q50946765 | ||
| IL-10/TGF-beta-treated dendritic cells, pulsed with insulin, specifically reduce the response to insulin of CD4+ effector/memory T cells from type 1 diabetic individuals. | Q51050539 | ||
| In vivo induction of type 1-like regulatory T cells using genetically modified B cells confers long-term IL-10-dependent antigen-specific unresponsiveness | Q56899837 | ||
| CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity | Q56904531 | ||
| Induction of IL-10 producing CD4+ T cells with regulatory activities by stimulation with IL-10 gene-modified bone marrow derived dendritic cells | Q64376626 | ||
| An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct | Q72411299 | ||
| Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse | Q73153290 | ||
| Human peripheral blood monocyte-derived interleukin-10-induced semi-mature dendritic cells induce anergic CD4(+) and CD8(+) T cells via presentation of the internalized soluble antigen and cross-presentation of the phagocytosed necrotic cellular fra | Q74684911 | ||
| P433 | issue | 7 | |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 769-780 | |
| P577 | publication date | 2012-05-11 | |
| P1433 | published in | Human Gene Therapy | Q15757580 |
| P1476 | title | Cytokine-conditioned dendritic cells induce humoral tolerance to protein therapy in mice | |
| P478 | volume | 23 |
| Q39022950 | Approaches to Mitigate the Unwanted Immunogenicity of Therapeutic Proteins during Drug Development. |
| Q36928899 | Exposure to factor VIII protein in the presence of phosphatidylserine induces hypo-responsiveness toward factor VIII challenge in hemophilia A mice |
| Q43218590 | IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII. |
| Q90836400 | Immunogenicity of Protein Pharmaceuticals |
| Q52836537 | Peanut allergens are rapidly transferred in human breast milk and can prevent sensitization in mice. |
| Q38090391 | Progress toward inducing immunologic tolerance to factor VIII. |
| Q38308222 | Strategies for reducing inhibitor formation in severe haemophilia |
Search more.